Article
Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.
Journal of clinical microbiology - 1 Feb 1995
Frenkel L M, Wagner L E, Atwood S M, Cummins T J, Dewhurst S
Abstract excerpt
The effectiveness of antiretroviral therapy may be limited by the development of human immunodeficiency virus type 1 (HIV-1) resistance. Monitoring for resistance will perhaps allow changes in therapy prior to deterioration in the patient's clinical or immunologic status. Our objective was to develop a rapid, specific, and sensitive genotypic assay for HIV-1 resistance to zidovudine (ZDV) and didanosine (ddI)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
